https://www.jnjmedicalcloud.co.uk/en-gb/subscriptions/thank-you2025-10-28T14:22:26.378Zhttps://www.jnjmedicalcloud.co.uk/en-gb/subscriptions/confirm2025-07-16T10:04:36.474Zhttps://www.jnjmedicalcloud.co.uk/en-gb/subscriptions/consent-information2025-07-16T10:04:17.892Zhttps://www.jnjmedicalcloud.co.uk/en-gb/cookie-policy2026-01-27T14:58:15.318Zhttps://www.jnjmedicalcloud.co.uk/en-gb/legal-notice2026-01-27T14:50:44.028Zhttps://www.jnjmedicalcloud.co.uk/en-gb2025-04-08T22:08:33.749Zhttps://www.jnjmedicalcloud.co.uk/en-gb/subscriptions2026-04-03T09:27:29.483Zhttps://www.jnjmedicalcloud.co.uk/en-gb/services2026-03-02T20:07:37.884Zhttps://www.jnjmedicalcloud.co.uk/en-gb/services/contact-jnj/call-us2025-03-13T10:12:35.899Zhttps://www.jnjmedicalcloud.co.uk/en-gb/services/contact-jnj/email-us2025-03-13T10:12:35.899Zhttps://www.jnjmedicalcloud.co.uk/en-gb/services/contact-jnj2025-03-13T10:12:35.899Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/prostate-cancer/erleada/evidence2026-03-12T11:10:47.778Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/bladder-cancer/balversa/resources2025-08-05T16:12:32.968Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/eha-2025-abstracts2025-07-28T14:56:26.969Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/learning/immunology-overview2026-04-01T16:30:24.067Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/learning/bispecific-antibodies2026-04-01T16:29:00.609Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/learning/car-t-therapy2026-04-01T16:27:42.706Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/learning/minimal-residual-disease2026-04-01T16:26:03.439Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/talvey/clinical-data/efficacy2026-03-18T14:07:41.173Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/talvey/clinical-data/safety2026-03-18T14:30:51.667Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/talvey/clinical-data/study-design2026-03-18T13:51:50.371Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/talvey/resources2026-02-25T13:40:51.311Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/cll-fixed-duration/efficacy2026-03-25T06:41:00.796Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/gastroenterology/tremfya/resources2026-03-17T10:34:58.612Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/prostate-cancer/erleada/nice-guidance2026-03-03T09:33:33.326Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex/dvrd2026-03-11T12:00:40.483Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/opsumit/dispersible2025-09-18T12:17:09.070Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/carvykti/patient-journey2026-03-17T11:45:37.453Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/carvykti/efficacy2026-03-17T11:43:50.384Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/carvykti/study-design2026-03-17T11:42:25.185Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/carvykti/technology2026-03-17T11:40:18.548Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/carvykti2026-03-17T11:37:26.971Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events2026-03-06T13:13:18.057Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/carvykti/ae-profile2026-03-12T14:38:27.543Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/gastroenterology2026-02-19T12:15:59.273Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/talvey/resources/expert-opinions2026-02-09T16:13:06.282Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/lung-cancer/rybrevant/papillon-efficacy2026-02-25T16:27:46.095Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex/key-prescribing-considerations2025-07-10T07:44:16.195Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex/dvcd2025-07-10T07:44:16.195Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex2026-02-17T13:35:15.819Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/ndmm-on-demand2026-02-25T20:23:19.640Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/lats/expert-insights2026-02-24T09:07:10.606Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/downloadable-resources2026-02-18T07:54:44.818Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/tecvayli/safety2026-02-16T12:22:55.345Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/ash-2025-p2p-highlights2026-01-30T13:07:45.695Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/lymphoma/non-hodgkin-lymphoma2025-12-17T08:10:32.307Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/tecvayli/majestec2026-01-06T12:58:34.867Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/tecvayli/mechanism-of-action2026-01-06T12:57:12.087Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/tecvayli2026-01-06T12:54:29.401Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/tecvayli/resources2026-01-06T11:37:11.538Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/tecvayli/retrostective2025-12-05T10:44:18.094Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/mcl2025-12-23T10:45:28.006Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/tecvayli/dosing-administration2025-12-16T11:15:38.033Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/referral-to-infusion2025-12-29T09:52:29.856Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/prostate-cancer/erleada/tolerability-nmcrpc2025-10-05T18:23:31.224Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/prostate-cancer/erleada2025-10-28T11:12:51.753Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/prostate-cancer/erleada/efficacy-nmcrpc2025-11-10T14:10:38.718Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/prostate-cancer/erleada/hrqol-nmcrpc2025-08-25T12:44:39.474Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/prostate-cancer/erleada/efficacy-mhspc2025-12-22T14:07:58.897Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/prostate-cancer/erleada/treat-early-nmcrpc2025-08-14T07:49:52.205Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/prostate-cancer/erleada/tolerability-mhspc2025-11-11T14:30:50.864Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/mcl/first-line-rchop2025-12-08T12:41:53.857Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/lung-cancer/rybrevant2025-12-08T08:53:39.208Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/mcl/relapsed-refractory2025-12-16T06:28:09.670Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/tecvayli/efficacy2025-11-24T11:56:27.486Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma2025-12-03T16:18:40.895Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology2025-11-20T09:23:43.681Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex/dvtd2025-11-24T17:15:04.755Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/talvey2025-11-26T14:52:29.444Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/simponi2025-09-25T12:31:07.788Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/cll-continuous-therapy2025-11-06T17:55:43.079Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/haematology-summit-20252025-10-31T08:38:30.212Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/cll-fixed-duration/safety2025-10-31T09:45:11.821Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/lung-cancer/rybrevant/mariposa-efficacy2025-10-14T12:15:00.697Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/lung-cancer/rybrevant/safety-tolerability-profile2025-10-09T11:43:32.156Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex/drd2025-09-24T11:18:02.332Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/tremfya2025-09-18T20:33:45.177Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/cll-fixed-duration/moa2025-10-03T13:24:07.960Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex/hcp-resources2025-09-29T10:28:30.521Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex/dvd2025-09-29T12:06:28.548Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph2025-07-10T07:44:16.195Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/cll-fixed-duration/value-of-iv-in-practice2025-09-10T14:27:51.996Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex/patient-resources2025-09-15T09:08:14.868Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/opsumit/film-coated2025-09-01T10:35:33.664Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/opsumit2025-07-29T09:41:45.849Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/gastroenterology/tremfya/how-it-works2025-08-11T08:43:39.098Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/gastroenterology/tremfya2025-08-05T09:58:28.126Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica2025-08-22T08:06:59.979Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/cll-fixed-duration/challenge-fitness2025-08-28T20:42:14.254Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/mte-webinar-20252025-08-20T12:32:49.464Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology2025-07-28T08:25:52.580Zhttps://www.jnjmedicalcloud.co.uk/en-gb/oncology/bladder-cancer/balversa2025-08-06T09:21:08.302Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/bsh-20242025-07-02T14:36:33.470Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/eha-2025-p2p-highlights2025-07-30T10:35:43.445Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/lats/the-paliperidone-plan2025-07-10T08:31:20.994Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/lats2025-06-17T09:11:42.439Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/tremfya/visible-study2025-06-24T09:35:36.501Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/diagnosis/screening-for-pah-in-ssc2025-06-06T13:10:46.381Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/what-is-pah2025-06-06T13:30:15.288Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/management/prognosis2025-07-07T11:16:48.522Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/bsh-20252025-07-08T14:49:44.232Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/simponi/resources2025-07-03T09:30:50.742Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/dermatology2025-06-19T15:30:58.397Zhttps://www.jnjmedicalcloud.co.uk/en-gb/immunology/rheumatology2025-06-19T15:12:47.708Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/adhd/concerta-xl2025-06-02T12:43:15.209Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/cll-webinar-20242025-03-10T14:41:59.986Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/management2025-05-13T10:26:22.515Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/cll-fixed-duration/dosing2025-04-11T15:52:11.175Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/al-amyloidosis/clinical-guidelines2025-03-12T21:27:32.857Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views2025-04-23T14:15:08.334Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/hartley-taylor-20242025-04-24T13:28:41.027Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/evolving-multiple-myeloma-landscape-bsh-20242025-04-11T12:00:54.434Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/t-cell-engaging-therapies/car-t-cell-therapy2025-04-29T12:16:04.218Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/current-treatment-pathways-in-mm2025-04-14T07:00:44.908Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/essential-role-of-nurses2025-05-13T12:23:47.804Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/haematology-summit-20242025-04-24T13:25:20.813Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/multiple-myeloma/staging-and-prognosis2025-04-29T12:25:40.826Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/t-cell-engaging-therapies/mitigating-and-managing-aes2025-04-29T12:41:19.018Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/multiple-myeloma/clinical-guidelines2025-03-13T15:25:30.718Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/rwe/chapter4-connecting-real-world-data-to-real-life-patients2025-02-05T15:27:45.759Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/rwe/chapter3-review-of-fire2025-02-05T15:14:58.475Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/standout-moments2025-05-13T12:22:40.921Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/treating-non-transplant-eligible-patients2025-05-13T12:26:36.302Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/t-cell-engaging-therapies/bispecific-antibody-therapy2025-04-29T11:30:14.342Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/al-amyloidosis/management2025-05-13T10:33:26.994Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/complexities-of-car-t2025-05-13T12:24:27.031Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/communication-is-key-in-car-t2025-05-13T12:23:14.320Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/unmet-need-in-frontline-mm2025-05-13T12:19:10.913Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/lymphoma/disease-management/mature-b-cell-neoplasms2025-05-13T10:28:24.010Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/dosing-management2025-03-24T09:22:37.790Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/patient-cases2025-04-25T13:46:41.132Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/unmet-need-for-patients-with-high-risk-mm2025-05-13T12:25:58.082Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/bispecific-antibodies2025-05-13T12:20:19.592Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/understanding-crs2025-04-29T10:58:55.527Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/10-year-series2025-03-25T13:17:37.401Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/understanding-icans2025-04-29T11:17:52.244Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/lymphoma/disease-management/mature-b-cell-neoplasms/mcl-management2025-04-28T15:51:17.721Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/al-amyloidosis/staging-and-prognosis2025-04-28T21:17:52.604Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/rwe/chapter5-translating-real-world-evidence-into-day-to-day-clinical-practice2025-02-05T15:30:43.503Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/rwe/chapter1-introduction-to-real-world-evidence2025-02-05T15:26:08.201Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management2025-03-27T12:20:21.053Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/opportunities-for-treatment-for-multiple-myeloma2025-05-13T12:21:49.146Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/t-cell-engaging-therapies/patient-selection2025-04-28T15:43:38.683Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/dvtd-impact-patient-experience-and-outcome2025-05-13T12:25:25.430Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/eha-2024-p2p-highlights2025-03-10T15:04:54.822Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/lymphoma/disease-management/mature-b-cell-neoplasms/staging-and-prognosis2025-04-02T13:56:34.378Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/multiple-myeloma/management2025-04-29T11:22:39.101Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/panel-debate-asct-newly-diagnosed2025-05-01T11:29:18.750Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/differences-between-transplant-eligible-non-eligible2025-04-11T16:05:37.829Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/talvey/dosing2025-05-02T15:37:12.661Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/multiple-myeloma/symptoms-and-diagnosis2025-04-29T13:45:15.021Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/renal-impairment-graham-jackson2025-04-11T11:18:26.534Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/multiple-myeloma/learning-videos2025-04-29T13:52:12.122Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/lymphoma/disease-management/mature-b-cell-neoplasms/clinical-guidelines2025-04-24T13:36:02.212Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry2025-05-13T13:04:32.392Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/talvey/mode-of-action2025-05-02T17:00:25.402Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/lymphoma2025-05-02T14:35:36.041Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/lymphoma/disease-management/mature-b-cell-neoplasms/symptoms-and-diagnosis2025-04-28T20:55:21.619Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/optimising-treatment-combinations2025-05-13T12:21:03.104Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/al-amyloidosis2025-05-13T10:32:22.922Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/darzalex/moa2025-04-01T10:17:51.892Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/t-cell-engaging-therapies2025-04-29T11:25:15.314Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/events/nurse-study-day-20242025-03-10T21:00:10.417Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/expert-views/treating-transplant-eligible-patients2025-05-07T14:33:28.114Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/lymphoma/disease-management/mature-b-cell-neoplasms/cll-management2025-04-28T14:02:36.936Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/imbruvica/rwe/home/video/chapter2-a-review-of-australia-pbs2025-05-11T21:11:31.203Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/multiple-myeloma2025-05-13T10:34:43.586Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/talvey/eligibility2025-04-24T11:00:12.349Zhttps://www.jnjmedicalcloud.co.uk/en-gb/haematology/myeloma/disease-management/al-amyloidosis/symptoms-and-diagnosis2025-04-29T11:07:18.229Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/what-is-pah/pathophysiology2025-04-28T11:31:35.867Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/diagnosis/symptoms-and-diagnosis2025-04-08T13:47:18.032Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/congresses2025-05-07T20:25:58.810Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/diagnosis/echocardiographic-assessment-of-ph2025-05-07T20:06:34.370Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/referral/specialist-care-for-ph2025-04-15T09:17:10.744Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/what-is-pah/fast-facts-on-pah2025-05-13T10:22:45.508Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah/management/palliative-care-in-pah2025-04-28T12:36:10.805Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/actonpah2025-04-04T07:37:22.484Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource2025-03-03T12:18:14.659Zhttps://www.jnjmedicalcloud.co.uk/en-gb/infectious-diseases2025-04-28T11:35:03.545Zhttps://www.jnjmedicalcloud.co.uk/en-gb/ph/uptravi2025-04-28T15:40:53.165Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/video-tutorials/intramuscular/conclusion2025-03-26T11:12:31.937Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/video-tutorials/intramuscular/administration-vastus2025-03-26T11:26:21.993Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/video-tutorials/intramuscular/administration-ventrogluteal2025-03-26T11:41:32.769Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/video-tutorials/intramuscular/administration-dorsogluteal2025-03-26T11:42:54.047Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/video-tutorials/intramuscular/administration-deltoid2025-03-26T11:44:04.014Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/video-tutorials/intramuscular/z-track2025-03-26T12:01:11.990Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/video-tutorials/intramuscular/general2025-03-26T12:02:24.815Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/resources2024-08-14T15:00:26.510Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/video-tutorials2025-03-03T11:56:35.459Zhttps://www.jnjmedicalcloud.co.uk/en-gb/psychiatry/reach4resource/schizophrenia/interactive-courses-online2024-08-14T15:03:51.391Z